Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular metabolic and reparative pathways represent a broad and heterogeneous collection of biochemical processes essential for maintaining cellular life, energy production, and genomic integrity (Alberts et al., Molecular Biology of the Cell, 2014). These pathways include central carbon metabolism, such as glycolysis and the citric acid cycle, as well as various DNA damage response (DDR) mechanisms like base excision repair and homologous recombination (Hanahan & Weinberg, Cell, 2011). While these processes are fundamental to health, they are frequently dysregulated in diseases like cancer, where metabolic reprogramming supports rapid growth, or in liver disease, where metabolic clearance is impaired. In clinical practice, certain agents like Metadoxine are described as enhancing these pathways to accelerate the metabolism of toxins like ethanol (Addolorato et al., Int J Immunopathol Pharmacol, 2003). However, because this term describes a functional category rather than a single protein or receptor, it is not considered a specific therapeutic target; instead, drug discovery efforts focus on individual enzymes or signaling molecules within these pathways, such as PARP for DNA repair or AMPK for metabolism (Lord & Ashworth, Nature, 2012).
Drugs associated with these pathways act through diverse mechanisms, including the activation of metabolic sensors like AMPK, the inhibition of DNA repair enzymes like PARP, or the provision of metabolic precursors to enhance detoxification and cellular repair (Lord & Ashworth, Nature, 2012; Addolorato et al., Int J Immunopathol Pharmacol, 2003).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular metabolic and reparative pathways.